Of 9 guidance figures from Astera Labs's earnings releases that Stock Atlas has scored against the reported result, 9 came in above the guide, 0 in range and 0 below. It met or beat its own guidance 100% of the time.
| Period | Measure | Guided | Reported | Result |
|---|---|---|---|---|
| Q2 FY26 | Revenue | $355.00M to $365.00M | $392.40M | above |
| Q1 FY26 | Revenue | $286.00M to $297.00M | $308.36M | above |
| Q4 FY25 | Revenue | $245.00M to $253.00M | $270.58M | above |
| Q3 FY25 | Diluted EPS | $0.38 to $0.39 | $0.50 | above |
| Q3 FY25 | Revenue | $203.00M to $210.00M | $230.57M | above |
| Q2 FY25 | Revenue | $170.00M to $175.00M | $191.93M | above |
| Q1 FY25 | Revenue | $151.00M to $155.00M | $159.44M | above |
| Q4 FY24 | Revenue | $126.00M to $130.00M | $141.10M | above |
Above means the reported figure beat the top of the range, in range that it landed inside it or on a point guide, below that it missed. Every guide and revision, and screens across companies, are in the research platform.
Do companies beat their own guidance? The study · Back to Astera Labs financials
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Astera Labs (ALAB) guidance record”, stockatlas.com/companies/ALAB/guidance/, data as of 3 November 2026. Links to this page are welcome.
